AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DIAZEPAM BP
4 registrations across 3 African markets— 2 active
Markets with DIAZEPAM BP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CALM 5 TABLETS TABLETS | 🇷🇼Rwanda | LABORATORY & ALLIED LTD | active | Oct 2029 |
| COZEPAM 5 TABLETS Tablet | 🇰🇪Kenya | COSMOS LIMITED | active | May 2029 |
| DIZAM 10MG/2ML INJECTION 10MG/2ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2007 |
| DIZAM 5MG 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2007 |
DIAZEPAM BP in Africa — Regulatory Overview
DIAZEPAM BP is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.